411 related articles for article (PubMed ID: 20868401)
1. An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention.
Forcier M; Musacchio N
Dermatol Ther; 2010; 23(5):458-76. PubMed ID: 20868401
[TBL] [Abstract][Full Text] [Related]
2. New quadrivalent HPV vaccine developments.
Tovar JM; Bazaldua OV
Postgrad Med; 2008 Nov; 120(4):14-6. PubMed ID: 19020361
[TBL] [Abstract][Full Text] [Related]
3. [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].
Malinova M
Akush Ginekol (Sofiia); 2015; 54 Suppl 1():25-31. PubMed ID: 26137767
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and natural history of genital human papillomavirus infection.
Weaver BA
J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S2-8. PubMed ID: 16729554
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.
Serrano B; de Sanjosé S; Tous S; Quiros B; Muñoz N; Bosch X; Alemany L
Eur J Cancer; 2015 Sep; 51(13):1732-41. PubMed ID: 26121913
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic HPV vaccines: new interventions for cancer control.
Barr E; Sings HL
Vaccine; 2008 Nov; 26(49):6244-57. PubMed ID: 18694795
[TBL] [Abstract][Full Text] [Related]
7. HPV: diagnosis, prevention, and treatment.
Hathaway JK
Clin Obstet Gynecol; 2012 Sep; 55(3):671-80. PubMed ID: 22828099
[TBL] [Abstract][Full Text] [Related]
8. Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines.
Dunne EF; Friedman A; Datta SD; Markowitz LE; Workowski KA
Clin Infect Dis; 2011 Dec; 53 Suppl 3():S143-52. PubMed ID: 22080267
[TBL] [Abstract][Full Text] [Related]
9. Genital human papillomavirus infection.
Dunne EF; Markowitz LE
Clin Infect Dis; 2006 Sep; 43(5):624-9. PubMed ID: 16886157
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
Broomall EM; Reynolds SM; Jacobson RM
Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
[TBL] [Abstract][Full Text] [Related]
11. Quadrivalent human papillomavirus vaccine.
Barr E; Tamms G
Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
[TBL] [Abstract][Full Text] [Related]
12. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
Goldstone SE; Vuocolo S
Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
[TBL] [Abstract][Full Text] [Related]
13. Harnessing the power of prevention: human papillomavirus vaccines.
Mayeaux EJ
Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s15-21. PubMed ID: 16520680
[TBL] [Abstract][Full Text] [Related]
14. Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia.
Pathirana D; Hillemanns P; Petry KU; Becker N; Brockmeyer NH; Erdmann R; Gissmann L; Grundhewer H; Ikenberg H; Kaufmann AM; Klusmann J; Kopp I; Pfister H; Rzany B; Schneede P; Schneider A; Smola S; Winter-Koch N; Wutzler P; Gross G
Vaccine; 2009 Jul; 27(34):4551-9. PubMed ID: 19524337
[TBL] [Abstract][Full Text] [Related]
15. Vulvo-vaginal cancers: risks, evaluation, prevention and early detection.
Duong TH; Flowers LC
Obstet Gynecol Clin North Am; 2007 Dec; 34(4):783-802, x. PubMed ID: 18061869
[TBL] [Abstract][Full Text] [Related]
16. Getting to know human papillomavirus (HPV) and the HPV vaccines.
Smith GD; Travis L
J Am Osteopath Assoc; 2011 Mar; 111(3 Suppl 2):S29-34. PubMed ID: 21415377
[TBL] [Abstract][Full Text] [Related]
17. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
; Dillner J; Kjaer SK; Wheeler CM; Sigurdsson K; Iversen OE; Hernandez-Avila M; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch FX; Joura EA; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Maansson R; Lu S; Vuocolo S; Hesley TM; Barr E; Haupt R
BMJ; 2010 Jul; 341():c3493. PubMed ID: 20647284
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer.
Chelimo C; Wouldes TA; Cameron LD; Elwood JM
J Infect; 2013 Mar; 66(3):207-17. PubMed ID: 23103285
[TBL] [Abstract][Full Text] [Related]
19. A review of clinical trials of human papillomavirus prophylactic vaccines.
Schiller JT; Castellsagué X; Garland SM
Vaccine; 2012 Nov; 30 Suppl 5(0 5):F123-38. PubMed ID: 23199956
[TBL] [Abstract][Full Text] [Related]
20. [HPV-infection].
Schmidt-Petruschkat S
MMW Fortschr Med; 2007 Mar; 149(12):29-31. PubMed ID: 17674887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
